A retrospective observational study comparing Insulin-glargine (Toujeo) versus insulin degludec

Trial Profile

A retrospective observational study comparing Insulin-glargine (Toujeo) versus insulin degludec

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Dec 2017

At a glance

  • Drugs Insulin glargine (Primary) ; Insulin degludec
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LIGHTNING
  • Most Recent Events

    • 12 Dec 2017 Results from LIGHTNING and Deliver D studies published in a Sanofi media release.
    • 05 Dec 2017 New trial record
    • 30 Nov 2017 According to a Sanofi media release, results from the study were presented at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top